DR. RANDALL WHITCOMB, M.D.
Osteopathic Medicine at High Hollow Dr, Ann Arbor, MI

License number
Michigan 4301060603
Category
Osteopathic Medicine
Type
Endocrinology, Diabetes & Metabolism
Address
Address
1527 High Hollow Dr, Ann Arbor, MI 48103
Phone
(734) 276-9007

Personal information

See more information about RANDALL WHITCOMB at radaris.com
Name
Address
Phone
Randall Whitcomb
5333 Mcauley Dr, Ypsilanti, MI 48197
(734) 434-4430
Randall W Whitcomb, age 70
1527 High Hollow Dr, Scio Township, MI 48103
(734) 769-8062
Randall Whitcomb
Ann Arbor, MI
(734) 769-8062

Professional information

Randall Whitcomb Photo 1

Sulfonylurea-Glitazone Combinations For Diabetes

US Patent:
5859037, Jan 12, 1999
Filed:
Nov 13, 1997
Appl. No.:
8/970057
Inventors:
Randall Wayne Whitcomb - Ann Arbor MI
Assignee:
Warner-Lambert Company - Morris Plains NJ
International Classification:
A61K 31425, A61K 31175
US Classification:
514369
Abstract:
Combinations of a sulfonylurea antidiabetic agent and a glitazone antidiabetic agent are useful for treating diabetes mellitus and improving glycemic control.


Randall Whitcomb Photo 2

Sulfonylurea-Glitazone Combinations For Diabetes

US Patent:
5972973, Oct 26, 1999
Filed:
Oct 16, 1998
Appl. No.:
9/173911
Inventors:
Randall Wayne Whitcomb - Ann Arbor MI
Assignee:
Warner-Lambert Company - Morris Plains NJ
International Classification:
A61K 3155, A61K 31495, A61K 3144, A61K 3147
US Classification:
514342
Abstract:
Combinations of a sulfonylurea antidiabetic agent and a glitazone antidiabetic agent are useful for treating diabetes mellitus and improving glycemic control.


Randall Whitcomb Photo 3

Combinations For Diabetes

US Patent:
6011049, Jan 4, 2000
Filed:
Nov 9, 1998
Appl. No.:
9/189132
Inventors:
Randall Wayne Whitcomb - Ann Arbor MI
Assignee:
Warner-Lambert Company - Morris Plains NJ
International Classification:
A61K 3144, A61K 31425, A61K 31175, A61K 31155
US Classification:
514369
Abstract:
Combinations of a glitazone antidiabetic agent and a biguanide antidiabetic agent, and optionally a sulfonylurea antidiabetic agent, are useful for treating diabetes mellitus and improving glycemic control.